Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neoplasms and MELK[original query] |
|---|
| Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias. Genes, chromosomes & cancer 2014 Jul 53 (7): 579-88. Sarhadi Virinder Kaur, Lahti Leo, Scheinin Ilari, Ellonen Pekka, Kettunen Eeva, Serra Massimo, Scotlandi Katia, Picci Piero, Knuutila Saka |
| An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast cancer (Dove Medical Press) 2017 9 95-110. Koleck Theresa A, Bender Catherine M, Clark Beth Z, Ryan Christopher M, Ghotkar Puja, Brufsky Adam, McAuliffe Priscilla F, Rastogi Priya, Sereika Susan M, Conley Yvette |
| Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer. BMC urology 2021 2 21 (1): 29. Wang Lijuan, Pan Shucheng, Zhu Binbin, Yu Zhenliang, Wang W |
| MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy. American journal of cancer research 2021 10 11 (9): 4421-4437. Oshi Masanori, Gandhi Shipra, Huyser Michelle R, Tokumaru Yoshihisa, Yan Li, Yamada Akimitsu, Matsuyama Ryusei, Endo Itaru, Takabe Kazua |
- Page last reviewed:Feb 1, 2024
- Content source:

